It caters to the critical needs of pharmaceutical manufacturers, research laboratories, and clinical supply chains, widely applied in treating partial-onset seizures in adults, diabetic peripheral neuropathy, postherpetic neuralgia, and generalized anxiety disorder. Produced under strict GMP guidelines, every batch undergoes rigorous purity and potency testing to meet international pharmacopoeia standards. For businesses prioritizing reliability, efficacy, and regulatory compliance, this Pregabalin API serves as a cornerstone raw material for developing high-quality central nervous system medications that address unmet clinical needs.
